Back to SAGE Stock Lookup

SAGE Therapeutics (SAGE) – Analyst Ratings

Jun 1, 2022 11:18 AM Raymond James Reiterates Market Perform Rating on Sage Therapeutics (SAGE), Sees Limited Upside to Stock Despite Strong zuranolone Data
Jun 1, 2022 07:54 AM UPDATE: CORRECTION: Stifel Reiterates Buy Rating on SAGE Therapeutics (SAGE), "Approvability of zuranolone in MDD" Remains Key Question
May 4, 2022 06:23 AM
May 3, 2022 10:46 AM
Mar 31, 2022 06:03 AM
Mar 22, 2022 08:39 AM
Mar 8, 2022 04:10 PM
Feb 25, 2022 07:10 AM
Feb 24, 2022 10:19 AM
Feb 24, 2022 10:19 AM
Feb 24, 2022 07:26 AM
Feb 16, 2022 11:45 AM
Feb 16, 2022 09:50 AM
Feb 16, 2022 07:55 AM
Jan 19, 2022 07:14 AM
Jan 18, 2022 06:15 AM
Jan 12, 2022 08:05 AM
Jan 6, 2022 06:40 AM
Dec 1, 2021 08:28 AM
Nov 2, 2021 01:54 PM
Nov 2, 2021 11:24 AM
Oct 19, 2021 08:26 AM
Oct 6, 2021 04:18 PM
Sep 22, 2021 04:13 PM
Jul 27, 2021 07:22 AM
Jul 16, 2021 09:12 AM
Jul 15, 2021 06:36 AM
Jun 28, 2021 06:04 AM
Jun 22, 2021 07:00 AM
Jun 21, 2021 08:00 AM
Jun 21, 2021 07:38 AM
Jun 16, 2021 07:26 AM
Jun 16, 2021 05:50 AM
Jun 15, 2021 12:46 PM
Jun 15, 2021 12:07 PM
Jun 15, 2021 11:49 AM
Jun 15, 2021 10:22 AM
Jun 15, 2021 10:10 AM
May 4, 2021 12:52 PM
Apr 19, 2021 09:14 AM
Apr 12, 2021 08:17 AM
Apr 7, 2021 04:49 AM
Feb 26, 2021 05:21 AM
Feb 25, 2021 06:55 AM
Feb 1, 2021 04:25 PM
Jan 22, 2021 05:35 AM
Jan 6, 2021 06:27 AM
Jan 4, 2021 06:19 AM
Jan 4, 2021 05:39 AM
Dec 17, 2020 12:49 PM

Back to SAGE Stock Lookup